RESUMO
New virulence factors, such as the Panton-Valentine leukocidin (PVL), are appearing during Staphylococcus aureus infections occurring in the pediatric population. Such factors increase the aggressiveness and risk of dissemination of the bacteria, causing infections to be life-threatening. An early diagnosis is thus especially important. We present a case of osteomyelitis, venous thrombosis, and septic emboli occurring in a pediatric patient that should trigger suspicion of a PVL-positive strain. A multidisciplinary approach is necessary to enable rapid diagnosis and early treatment, which is essential for successful management of these infections. Management is based on broad-spectrum antibiotics, in combination with aggressive surgical treatment and antithrombotic therapy. In patients infected with S. aureus whose condition worsens quickly, PVL gene sequencing should be considered.
Assuntos
Osteomielite/etiologia , Trombose Venosa/etiologia , Antibacterianos/uso terapêutico , Toxinas Bacterianas/análise , Toxinas Bacterianas/sangue , Criança , Exotoxinas/análise , Exotoxinas/sangue , Feminino , Humanos , Unidades de Terapia Intensiva Pediátrica/organização & administração , Unidades de Terapia Intensiva Pediátrica/estatística & dados numéricos , Leucocidinas/análise , Leucocidinas/sangue , Osteomielite/complicações , Osteomielite/fisiopatologia , Infecções Estafilocócicas/diagnóstico , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/patogenicidade , Trombose Venosa/tratamento farmacológico , Trombose Venosa/fisiopatologiaRESUMO
INTRODUCTION: Extended-spectrum beta-lactamase (ESBL) producing bacteria are infrequent pathogens of urinary tract infections in children. The objective of our study was to investigate the presence, clinically associated characteristics and risk factors for acquisition of urinary tract infection/acute pyelonephritis (UTI/APN) in hospitalised children <2years old caused by community-acquired ESBL. METHODS: A case-control study in a second level community hospital in Spain, in which 537 episodes of UTI/APN were investigated in a retrospective study between November 2005 and August 2014. Cases were patients with ESBL strains. For each case, four ESBL-negative controls were selected. A questionnaire with the variables of interest was completed for every patient, and the groups were compared. RESULTS: ESBL-positive strains were found in 19 (3,5%) cultures. Of these 16 (84%) were Escherichia coli. Vesicoureteral reflux (VUR) of any grade was more frequent in the ESBL group (60 vs. 29%), although without statistical significance. Relapses were more frequent in the ESBL group (42% vs. 18%) (P=.029; OR=3.2; 95%CI: 1.09-9.5). The prevalence of UTI/APN due to ESBL-positive strains increased slightly from 2.7% in the period 2005-2009 to 4.4% in the period 2010-2014. CONCLUSIONS: ESBL UTI/APN were associated with more frequent relapses. VUR of any grade was twice more frequent in the ESBL group. Piperacillin/tazobactam, fosfomycin and meropenem showed an excellent activity. Aminoglycosides may be a therapeutic option, and in our patients gentamicin was the antibiotic most used.
Assuntos
Proteínas de Bactérias/análise , Infecções Comunitárias Adquiridas/epidemiologia , Infecções Urinárias/epidemiologia , Resistência beta-Lactâmica , beta-Lactamases/análise , Estudos de Casos e Controles , Infecções Comunitárias Adquiridas/microbiologia , Comorbidade , Escherichia coli/enzimologia , Escherichia coli/isolamento & purificação , Infecções por Escherichia coli/epidemiologia , Infecções por Escherichia coli/microbiologia , Feminino , Febre/etiologia , Hospitais Comunitários/estatística & dados numéricos , Humanos , Lactente , Pacientes Internados , Masculino , Pielonefrite/epidemiologia , Pielonefrite/microbiologia , Estudos Retrospectivos , Fatores de Risco , Espanha/epidemiologia , Inquéritos e Questionários , Infecções Urinárias/microbiologia , Refluxo Vesicoureteral/epidemiologiaRESUMO
OBJECTIVES: Studies comparing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA load in the upper respiratory tract (URT) between children and adults-who either presented with coronavirus disease 2019 (COVID-19) or were asymptomatic-have yielded inconsistent results. Here, we conducted a retrospective, single-centre study to address this issue. PATIENTS AND METHODS: Included were 1184 consecutive subjects (256 children and 928 adults) testing positive for SARS-CoV-2 RNA in nasopharyngeal exudates (NPs); of these, 424 (121 children and 303 adults) had COVID-19 and 760 (135 children and 625 adults) were asymptomatic close contacts of COVID-19 patients. SARS-CoV-2 RNA testing was carried out using the TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, MS, USA). The AMPLIRUN® TOTAL SARS-CoV-2 RNA Control (Vircell SA, Granada, Spain) was used for estimating SARS-CoV-2 RNA loads (in copies/mL). SARS-CoV-2 RNA loads at the time of laboratory diagnosis (single specimen/patient) were used for comparison purposes. RESULTS: Median initial SARS-CoV-2 RNA load was lower (p 0.094) in children (6.98 log10 copies/mL, range 3.0-11.7) than in adults (7.14 log10 copies/mL, range 2.2-13.4) with COVID-19. As for asymptomatic individuals, median SARS-CoV-2 RNA load was comparable (p 0.97) in children (6.20 log10 copies/mL, range 1.8-11.6) and adults (6.48 log10 copies/mL, range 1.9-11.8). Children with COVID-19 symptoms displayed SARS-CoV-2 RNA loads (6.98 log10 copies/mL, range 3.0-11.7) comparable to those of their asymptomatic counterparts (6.20 log10 copies/mL, range 1.8-11.6) (p 0.61). Meanwhile in adults, median SARS-CoV-2 RNA load was significantly higher in symptomatic (7.14 log10 copies/mL, range 2.2-13.4) than in asymptomatic subjects (6.48 log10 copies/mL, range 1.9-11.8) (p < 0.001). Overall, the observed URT SARS-CoV-2 RNA clearance rate was faster in children than in adults. CONCLUSIONS: Based on viral load data at the time of diagnosis, our results suggest that SARS-CoV-2-infected children, with or without COVID-19, may display NP viral loads of comparable magnitude to those found in their adult counterparts. However, children may have shorter viral shedding than adults.
Assuntos
COVID-19 , Nasofaringe/virologia , RNA Viral , SARS-CoV-2 , Carga Viral , Adulto , Infecções Assintomáticas , COVID-19/diagnóstico , Criança , Humanos , RNA Viral/isolamento & purificação , Estudos RetrospectivosRESUMO
Introduction: Primary peritonitis (PP) and Ménétrier's Disease (MD) are both rare conditions among pediatric population. Although about 150 MD cases have been described in the scientific literature to date, its onset with a PP is an unusual condition. Case Presentation: We present a case of an 11-year-old boy who was admitted to our unit because of abdominal pain and distension. Complementary tests showed ascites, bilateral pleural effusion, leukocytosis, increased acute phase reactants and hypoproteinemia with hypoalbuminemia. Laparoscopy ruled out appendicitis or visceral perforations and exposed purulent peritoneal fluid, compatible with PP. Biochemical stool analysis showed increased clearance of alpha-1-antitrypsin, which was consistent with a protein-losing enteropathy. Gastroscopy findings were compatible with MD. The clinical course was favorable and he had no recurrence after 12 months of follow-up. Conclusion: PP can be the first clinical manifestation of pediatric MD. Knowledge of MD and its generally benign nature in children is important in order to avoid excessive testing and unnecessary treatment.
RESUMO
Introducción. Los objetivos de este trabajo fueron conocer la prevalencia de infecciones por Staphylococcus aureus resistente a meticilina (SARM) en la población pediátrica de nuestro departamento de salud, describir los factores de riesgo para infección por SARM frente a las producidas por S. aureus sensible a meticilina (SASM) y conocer el perfil de sensibilidad antibiótica de los aislados de SARM y SASM. Pacientes y métodos. Se realizó un estudio retrospectivo descriptivo y analítico de las infecciones producidas por SARM frente a las producidas por SASM durante los años 2014 al 2018. Se estudiaron las variables predictoras de SARM mediante un modelo de regresión logística binaria. Resultados. Se identificaron 162 pacientes con infecciones por S. aureus, 15,4% resistentes a meticilina. Los porcentajes mayores de infección por SARM se dieron entre los niños que precisaron ingreso hospitalario (23,4%). En el análisis univariante alcanzaron significación estadística la necesidad de ingreso hospitalario, el antecedente de haber recibido tratamiento antibiótico en los 3 meses previos, el tipo de infección y el antecedente de infección o colonización previa por SARM. En el modelo de regresión logística la necesidad de ingreso hospitalario y el tratamiento antibiótico reciente mantuvieron significación estadística. Solo recibieron tratamiento antibiótico correcto el 26,7% de los niños que ingresaron con infección por SARM. Conclusiones. Nuestros resultados sugieren la necesidad de revisar las pautas de tratamiento empírico usando fármacos activos frente a SARM en las infecciones de probable origen estafilocócico que ingresen en el hospital en niños sobre todo si han recibido tratamiento antibiótico reciente. (AU)
Introduction. The objectives of this work were to know the prevalence of methicillin-resistant S. aureus (MRSA) infections in the paediatric population of our health department, to describe the risk factors for infection by MRSA compared to those produced by methicillin-susceptible S. aureus (MSSA) and to know the antibiotic sensitivity profile of MRSA and MSSA isolates. Material and methods. A retrospective, descriptive and analytical study of infections produced by MRSA versus those produced by MSSA was carried out during the years 2014 to 2018. Risk factors for MRSA infection were studied using a binary logistic regression model. Results, 162 patients with S. aureus infections were identified. Of these, 25 (15.4%) were MRSA. The highest percentages of MRSA infection occurred among children who required hospital admission (23.4%). In the univariate analysis the need of hospital admission, antibiotic treatment in the last 3 months, the kind of infection and past MRSA infection or colonisation reached statistical significance. However, only the need of hospital admission and antibiotic treatment in the last 3 months maintained statistical significance in the binary logistic regression model. Correct antibiotic treatment was only prescribed in 26.7% of the MRSA infection cases admitted to the hospital. Conclusions. Our results suggest the need to review empirical local treatment regimen using drugs active against MRSA in infections of probable staphylococcal origin admitted to the hospital, especially if they have received antibiotic treatment in the last 3 months. (AU)
Assuntos
Humanos , Criança , Staphylococcus aureus , Resistência a Meticilina , Fatores de Risco , Prevalência , Hospitalização , Estudos Retrospectivos , Epidemiologia DescritivaRESUMO
INTRODUCCIÓN: El objetivo de nuestro estudio fue investigar la presencia, las características clínicas y los factores de riesgo para la adquisición de infección urinaria febril/pielonefritis (ITU/PNA) de la comunidad por microorganismos productores de betalactamasas de espectro extendido (BLEE+) en niños < 2 años que fueron ingresados en el hospital. MÉTODOS: Estudio de casos-controles en un hospital de segundo nivel en España. Se revisaron de forma retrospectiva 537 episodios de ITU/PNA entre noviembre de 2005 y agosto de 2014. Los casos fueron las ITU/PNA BLEE+. Por cada caso se escogieron 4 controles betalactamasas de espectro extendido negativos (BLEE−). Para cada paciente se rellenó un cuestionario con las variables de interés y se realizó la comparación entre los grupos. RESULTADOS: Se identificaron 19 casos (3,5%) BLEE+. De ellos, 16 (84%) fueron Escherichia coli. El reflujo vesicoureteral (RVU) de cualquier grado fue más frecuente en el grupo BLEE+ (60 vs. 29%), aunque la diferencia no alcanzó significación estadística. Las recurrencias fueron más frecuentes en el grupo BLEE+ (42% vs 18%) (p = 0,029; OR = 3,2; IC-95%: 1,09-9,5). La prevalencia de ITU/PNA BLEE+ se incrementó ligeramente desde el 2,7% en el periodo 2005-2009 al 4,4% en el periodo 2010-2014. CONCLUSIONES: Las ITU/PNA BLEE+ se asociaron a recurrencias más frecuentes. El RVU fue el doble de frecuente en el grupo BLEE+. Piperacilina/tazobactam, meropenem y fosfomicina mostraron una excelente actividad. Los aminoglucósidos pueden ser una opción terapéutica, y en nuestra serie la gentamicina fue el antibiótico más utilizado
INTRODUCTION: Extended-spectrum beta-lactamase (ESBL) producing bacteria are infrequent pathogens of urinary tract infections in children. The objective of our study was to investigate the presence, clinically associated characteristics and risk factors for acquisition of urinary tract infection/acute pyelonephritis (UTI/APN) in hospitalised children < 2 years old caused by community-acquired ESBL. METHODS: A case-control study in a second level community hospital in Spain, in which 537 episodes of UTI/APN were investigated in a retrospective study between November 2005 and August 2014. Cases were patients with ESBL strains. For each case, four ESBL-negative controls were selected. A questionnaire with the variables of interest was completed for every patient, and the groups were compared. RESULTS: ESBL-positive strains were found in 19 (3,5%) cultures. Of these 16 (84%) were Escherichia coli. Vesicoureteral reflux (VUR) of any grade was more frequent in the ESBL group (60 vs. 29%), although without statistical significance. Relapses were more frequent in the ESBL group (42% vs. 18%) (P = .029; OR = 3.2; 95%CI: 1.09-9.5). The prevalence of UTI/APN due to ESBL-positive strains increased slightly from 2.7% in the period 2005-2009 to 4.4% in the period 2010-2014. CONCLUSIONS: ESBL UTI/APN were associated with more frequent relapses. VUR of any grade was twice more frequent in the ESBL group. Piperacillin/tazobactam, fosfomycin and meropenem showed an excellent activity. Aminoglycosides may be a therapeutic option, and in our patients gentamicin was the antibiotic most used
Assuntos
Humanos , Criança , Infecções Urinárias/microbiologia , Pielonefrite/microbiologia , Fatores de Risco , Estudos de Casos e Controles , Infecções Comunitárias Adquiridas/microbiologia , beta-Lactamases/farmacocinéticaRESUMO
A group of 6 Cynomolgus monkeys was immunized with dengue 4 virus (H247 standard strain). 60 days after innoculation the cellular proliferation against the same serotype as well as against hetereologous serotypes 1 and 2 was measured. A proliferative response predominantly of the specific serotype and some cross reactivity were detected. These results showed a behavior of primates similar in some extent to that of human beings and mice regarding the specific serotype and cross serotype response to dengue virus.
Assuntos
Dengue/imunologia , Linfócitos/imunologia , Animais , Vírus da Dengue/classificação , Vírus da Dengue/imunologia , Macaca fascicularis , SorotipagemRESUMO
Se inmunizó con virus dengue 4 (cepa estándar H247), un grupo de 6 monos Cynomolgus y, 60 d después de la inoculación, se midió la proliferación celular frente al mismo serotipo, así como frente a los serotipos heterólogos 1 y 2. Se detectó una respuesta proliferativa predominantemente serotipo específica y alguna reactividad cruzada. Estos resultados evidencian un comportamiento de los primates en alguna medida similar al de humanos y ratones, en la respuesta serotipo específica y serotipo cruzada al virus dengue(AU)
Assuntos
Animais , Vírus da Dengue/imunologia , Vírus da Dengue/patogenicidade , Linfócitos T/imunologia , Imunidade Celular/imunologia , Macaca fascicularis/imunologiaRESUMO
Se inmunizó con virus dengue 4 (cepa estándar H247), un grupo de 6 monos Cynomolgus y, 60 d después de la inoculación, se midió la proliferación celular frente al mismo serotipo, así como frente a los serotipos heterólogos 1 y 2. Se detectó una respuesta proliferativa predominantemente serotipo específica y alguna reactividad cruzada. Estos resultados evidencian un comportamiento de los primates en alguna medida similar al de humanos y ratones, en la respuesta serotipo específica y serotipo cruzada al virus dengue